Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangzi Ke
Observed name:
Fang-Zi Ke
Institutions:
Wuhan University,
Zhongnan Hospital of Wuhan University
Observed institutions:
Wuhan University,
Zhongnan Hospital of Wuhan University,
Renmin Hospital of Wuhan University
OpenAlex ID:
A5087775627
MiR-155 promotes inflammation and apoptosis via targeting SIRT1 in hypoxic-ischemic brain damage
2023
·
Fangzi Ke
, Hongyun Wang
, et al.
·
Experimental Neurology
·
39
MicroRNA-124 negatively regulates STAT3 to alleviate hypoxic-ischemic brain damage by inhibiting oxidative stress
2024
·
Jiaqing Geng
, Jiangpeng Feng
, et al.
·
Aging
·
10
PDF
A Multifunctional Nanodelivery System Modified by Fusion Peptides Acts as Teriparatide Carrier for Noise‐Induced Hearing Loss Therapy
2025
·
Jiawen Li
, Jiawen Li
, et al.
·
Advanced Science
·
4
PDF
Multifunctional Self‐Assembling Peptide System for Preventing Noise‐Induced Hearing Loss
2026
·
Jiawen Li
, Jiawen Li
, et al.
·
Advanced Materials
·
3
Based on network pharmacology and experimental validation of β-sitosterol alleviates cisplatin-induced hearing loss via phosphorylated MAPK3
2026
·
Jiahao Meng
, Fangzi Ke
, et al.
·
Cellular Signalling
Gadd45a knockout alleviates cisplatin-induced hearing loss by inhibiting CXCL family protein expression
2026
·
Wei-Long Wang
, Sheng-Yu Zou
, et al.
·
Military Medical Research
Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction
2025
·
Zhihui Liu
, Baoai Han
, et al.
·
Redox Report
PDF
Show more works
View as search
Works count:
7
Citation count:
56
H-index:
3
I10-index:
2
Year
Topic
Type